H M Golomb

769 citations
22 papers · 516 indexed · h-index 13
Topics
Chronic Lymphocytic Leukemia Research (7 papers)Lung Cancer Treatments and Mutations (7 papers)Lymphoma Diagnosis and Treatment (5 papers)

In The Last Decade

H M Golomb

22 papers receiving 486 citations

Peers

H M Golomb
Comparison fields: 5 of 51
  • Hematology 265
  • Public Health, Environmental and Occupational Health 148
  • Oncology 139
  • Genetics 130
  • Molecular Biology 107
Replace Kristina Vermaelen with:
Kristina Vermaelen Belgium
E. Thiel Germany
CR Bartram Germany
SA Shurtleff United States
P Buchinger Austria
C Mecucci Italy
JD Tigaud France
RT Silver United States
I. Quiquandon France
T. Karakas Germany
H M Golomb relative to Kristina Vermaelen Belgium Kristina Vermaelen's profile →
Citations per field
00.5×
Kristina Vermaelen · 1×
Citations per year

Countries citing papers authored by H M Golomb

Since Specialization
Citations

This map shows the geographic impact of H M Golomb's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H M Golomb with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H M Golomb more than expected).

Fields of papers citing papers by H M Golomb

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H M Golomb. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H M Golomb. The network helps show where H M Golomb may publish in the future.

Co-authorship network of co-authors of H M Golomb

This figure shows the co-authorship network connecting the top 25 collaborators of H M Golomb. A scholar is included among the top collaborators of H M Golomb based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H M Golomb. H M Golomb is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 41
2
A review of ifosfamide and vinorelbine in advanced non-small cell carcinoma of the lung.
6
3 17
4
Vinorelbine (Navelbine), cisplatin, and concomitant radiation therapy for advanced malignancies of the chest: a Phase I study.
7
5 2
6
Recombinant alpha-2b-interferon in therapy of previously untreated hairy cell leukemia: long-term follow-up results of study by Cancer and Leukemia Group B.
28
7 3
8 1
9
Peripheral blood-derived stem cell collections for use in autologous transplantation after high dose chemotherapy: an alternative approach.
74
10 126
11 6
12
Guidelines for the treatment of hairy cell leukemia.
37
13 5
14
Treatment of myeloid blastic crisis of chronic myelogenous leukemia.
16
15
Non-small cell carcinoma of the lung.
12
16 22
17 48
18
Megaloblastic anemia during pregnancy.
2
19 14
20 33

About H M Golomb

H M Golomb is a scholar working on Genetics, Hematology and Pathology and Forensic Medicine, having authored 22 papers that have together received 516 indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (7 papers), Lung Cancer Treatments and Mutations (7 papers) and Lymphoma Diagnosis and Treatment (5 papers). The work is most often cited by research in Hematology (265 citations), Genetics (130 citations) and Pathology and Forensic Medicine (106 citations). H M Golomb has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include D Catovsky, Jorge R. Quesada, JW Vardiman, JD Rowley, JR Testa, S F Williams, Elizabeth Barker, Jacob D. Bitran, SylviaD. Lawler and Felix Mitelman. Their work appears in journals such as Journal of Clinical Oncology, Blood and Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026